John McKew
Präsident bei LUMOS PHARMA, INC.
Vermögen: 47 342 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von John McKew
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Pharmaceuticals: Major | 10 | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.
9
| Government | General Government | 9 |
Boston University School of Medicine
5
| College/University | Other Consumer Services | 5 |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.
2
| Subsidiary | Medical/Nursing Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von John McKew
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| SAVARA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Michigan | College/University | Chief Tech/Sci/R&D Officer Graduate Degree Corporate Officer/Principal | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chairman | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| Texas Tech University | College/University | Undergraduate Degree Undergraduate Degree | |
| GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Iowa | College/University | Corporate Officer/Principal Undergraduate Degree | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Corporate Officer/Principal | |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| UCSF School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| LDR HOLDING CORP | Medical Specialties | Director/Board Member Director/Board Member | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree | |
| New York University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Drake University Law School | College/University | Graduate Degree Graduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Doctorate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | General Counsel Corporate Officer/Principal | |
Pharmaco
 Pharmaco Drugstore ChainsRetail Trade Pharmaco acquires, develops and markets niche pharmaceutical products. The company was founded by Rick J. Hawkins in 1983 and is headquartered in Atlanta, GA. | Drugstore Chains | Chief Executive Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BioProtection Systems Corp.
 BioProtection Systems Corp. BiotechnologyHealth Technology Part of Lumos Pharma, Inc., BioProtection Systems Corp. is a private company that manufactures biological products. The company is based in Ames, IA. | Biotechnology | Chairman Director of Finance/CFO | |
LDR Spine USA, Inc.
 LDR Spine USA, Inc. Medical SpecialtiesHealth Technology LDR Spine USA, Inc. offers sterile spinal implant systems. Its product line which includes pre-sterilized fusion devices help in ensuring simple and reliable management of spinal implants. The company was founded in December 1999 and is headquartered in Austin, TX. | Medical Specialties | Director/Board Member Director/Board Member | |
| Iowa State University | College/University | Graduate Degree Graduate Degree | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
National Centre for Biological Sciences
 National Centre for Biological Sciences Miscellaneous Commercial ServicesCommercial Services The National Centre for Biological Sciences (NCBS) is a research institute located in Bangalore, IN. The Tata Institute for Genetics and Society (TIGS) is a non-profit research institute that aspires to develop solutions to challenges in human health and agriculture using applications of cutting-edge science and technology in genetics and genomics. The NCBS conducts research on various topics such as the assembly of mixed and branched heterotypic ubiquitin chains, evolution, and dopamine-neuropeptide axis maintenance in Drosophila. The institute has also been involved in tracking COVID and dengue through sewage surveillance. The institute is part of the Tata Institute of Fundamental Research and is dedicated to the study of stem cell and regenerative biology. The center for cellular and molecular platforms (C-CAMP) is an initiative of the Department of Biotechnology, Ministry of Science and Technology, with a mandate to be an enabler of cutting-edge life science research and innovation. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
Implant Therapeutics
 Implant Therapeutics Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., Implant Therapeutics is a Canadian biotechnology company that develops therapeutic products in the immunology, mesenchymal stem cell, and pancreatic islet space. The private company partners with other companies to develop novel products in other areas of regenerative medicine. Under the guidance of Dr. Mahendra Rao, Implant Therapeutics engineers hypoimmunogenic and safe-harbor technologies in ipsc-msc and islets. These cells are an ideal choice for bone, cartilage, and tendon replacement strategies, combining the advantages of allogeneic and autologous cells, as well as allowing them to be used as ex-vivo gene therapy vehicles. The CEO of the company is Mahendra S. Rao. | Miscellaneous Commercial Services | Chief Executive Officer | |
panCELLa, Inc.
 panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The private company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | Miscellaneous Commercial Services | Chairman | |
| MIRATI THERAPEUTICS | Biotechnology | Investor Relations Contact | |
| THERMOGENESIS HOLDINGS, INC. | Medical Specialties | Director/Board Member | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal | |
| National Institute on Aging | General Government | Corporate Officer/Principal | |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Founder | |
Q Therapeutic Products, Inc.
 Q Therapeutic Products, Inc. Miscellaneous Commercial ServicesCommercial Services Q Therapeutic Products, Inc. develops novel products to treat debilitating and fatal diseases. The company was founded by Dennis B. Farrar and Mahendra S. Rao in 2004 and is headquartered in Salt Lake, UT. | Miscellaneous Commercial Services | Founder | |
| AADI BIOSCIENCE, INC. | Biotechnology | Investor Relations Contact | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact |
Statistik
International
| Vereinigte Staaten | 46 |
| Kanada | 3 |
| Belgien | 2 |
| Indien | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 17 |
| Commercial Services | 10 |
| Retail Trade | 2 |
| Government | 2 |
Operativ
| Director/Board Member | 305 |
| Corporate Officer/Principal | 150 |
| Independent Dir/Board Member | 89 |
| Chairman | 50 |
| Chief Tech/Sci/R&D Officer | 47 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| Jon Saxe | 43 |
| Gil Omenn | 42 |
| Garry Neil | 38 |
| Edward Penhoet | 29 |
| Emmett Cunningham | 28 |
| Carole Nüchterlein | 26 |
| John Niederhuber | 25 |
| Kevin Lalande | 24 |
| Richard Hawkins | 21 |
| Nancy Andrews | 21 |
| Joseph McCracken | 20 |
| Lota Zoth | 20 |
| Thomas Raffin | 19 |
| Frédéric Chéreau | 17 |
- Börse
- Insiders
- John McKew
- Unternehmensverbindungen
